China · Delayed Price · Currency is CNY Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 24.66 billion. The enterprise value is 25.15 billion.
| Market Cap | 24.66B |
| Enterprise Value | 25.15B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jun 11, 2025 |
Share Statistics
Zhende Medical has 263.75 million shares outstanding. The number of shares has decreased by -1.29% in one year.
| Current Share Class | 263.75M |
| Shares Outstanding | 263.75M |
| Shares Change (YoY) | -1.29% |
| Shares Change (QoQ) | +8.14% |
| Owned by Insiders (%) | 10.07% |
| Owned by Institutions (%) | 4.55% |
| Float | 103.55M |
Valuation Ratios
The trailing PE ratio is 93.53 and the forward PE ratio is 50.27.
| PE Ratio | 93.53 |
| Forward PE | 50.27 |
| PS Ratio | 5.68 |
| PB Ratio | 4.11 |
| P/TBV Ratio | 6.19 |
| P/FCF Ratio | 175.31 |
| P/OCF Ratio | 43.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.98, with an EV/FCF ratio of 178.81.
| EV / Earnings | 95.28 |
| EV / Sales | 5.80 |
| EV / EBITDA | 34.98 |
| EV / EBIT | 64.52 |
| EV / FCF | 178.81 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.64 |
| Quick Ratio | 1.03 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 2.04 |
| Debt / FCF | 9.15 |
| Interest Coverage | 10.41 |
Financial Efficiency
Return on equity (ROE) is 4.55% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | 4.55% |
| Return on Assets (ROA) | 2.48% |
| Return on Invested Capital (ROIC) | 5.23% |
| Return on Capital Employed (ROCE) | 4.93% |
| Weighted Average Cost of Capital (WACC) | 6.97% |
| Revenue Per Employee | 555,713 |
| Profits Per Employee | 33,819 |
| Employee Count | 7,807 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.52 |
Taxes
In the past 12 months, Zhende Medical has paid 56.81 million in taxes.
| Income Tax | 56.81M |
| Effective Tax Rate | 17.26% |
Stock Price Statistics
The stock price has increased by +385.01% in the last 52 weeks. The beta is 0.54, so Zhende Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +385.01% |
| 50-Day Moving Average | 91.33 |
| 200-Day Moving Average | 64.41 |
| Relative Strength Index (RSI) | 55.36 |
| Average Volume (20 Days) | 2,762,812 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.34 billion and earned 264.02 million in profits. Earnings per share was 1.00.
| Revenue | 4.34B |
| Gross Profit | 1.44B |
| Operating Income | 327.67M |
| Pretax Income | 329.07M |
| Net Income | 264.02M |
| EBITDA | 625.92M |
| EBIT | 327.67M |
| Earnings Per Share (EPS) | 1.00 |
Balance Sheet
The company has 1.07 billion in cash and 1.29 billion in debt, with a net cash position of -219.04 million or -0.83 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 1.29B |
| Net Cash | -219.04M |
| Net Cash Per Share | -0.83 |
| Equity (Book Value) | 6.00B |
| Book Value Per Share | 21.03 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was 572.01 million and capital expenditures -431.33 million, giving a free cash flow of 140.68 million.
| Operating Cash Flow | 572.01M |
| Capital Expenditures | -431.33M |
| Depreciation & Amortization | 312.39M |
| Net Borrowing | 157.80M |
| Free Cash Flow | 140.68M |
| FCF Per Share | 0.53 |
Margins
Gross margin is 33.12%, with operating and profit margins of 7.55% and 6.09%.
| Gross Margin | 33.12% |
| Operating Margin | 7.55% |
| Pretax Margin | 7.58% |
| Profit Margin | 6.09% |
| EBITDA Margin | 14.43% |
| EBIT Margin | 7.55% |
| FCF Margin | 3.24% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | -48.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 77.32% |
| Buyback Yield | 1.29% |
| Shareholder Yield | 1.98% |
| Earnings Yield | 1.07% |
| FCF Yield | 0.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |